Putnam Investments LLC Bridge Bio Pharma, Inc. Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	BUY	$7.17 - $18.55 $95,733 - $247,679	13,352 Added 38.41%	48,114 $797,000
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $234,295 - $400,458	34,762 New	34,762 $264,000
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $1.53 Million - $2.38 Million	-56,338 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $1.25 Million - $2.01 Million	56,338 New	56,338 $1.84 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.